Original Publication Date: 19 January, 2014
Publication / Source: International Journal of Hematologic Oncology
Authors: Antonio Palumbo & Stefania Oliva
In the last few years many advances have been made in the understanding and treatment of multiple myeloma (MM). MM is a plasma cell neoplasm that accounts for approximately 10% of all hematologic malignancies, it is typical of the elderly, with a median age at diagnosis of 65 years .